A better understanding of how the beverage composition impacts phenolic profiles and their bioavailability is critical to development of beverage products designed to deliver specific health benefits.
The ability to manipulate these signaling events is critical to development of new classes of therapeutic agents that can promote process such as arteriogenesis or lymphangiogenesis, increase contractility of the failing heart or reverse myocardial hypertrophy.
An understanding of the dynamics driving the cycle of infectious disease is critical to development of such policies and to reducing the burden of infectious disease in California and around the world.
The second step is equally critical to development of a common agenda.
The modulation of chromatin structure and epigenetic memory is critical to development of complex organisms.
Understanding the plasticity of the fibrotic phenotype is critical to development of novel therapeutic approaches to fibrosis.
The molecular characterization of subgroups of tumors has become critical to development of new classes of anti-cancer agents.
Mentorship by attachment site mentors from the respective sites and primary mentors from the Afya Bora program was critical to development of locally relevant projects.
